IBDEI15Z ; ; 12-MAY-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1071,0)
 ;;=BIOFEEDBACK^1^90
 ;;^UTILITY(U,$J,358.4,1072,0)
 ;;=CASE MANAGEMENT^2^90
 ;;^UTILITY(U,$J,358.4,1073,0)
 ;;=INPT OR OTPT PSYTX W/O E&M^7^90
 ;;^UTILITY(U,$J,358.4,1074,0)
 ;;=INTERACTIVE COMPLEXITY ADD-ON^7^90
 ;;^UTILITY(U,$J,358.4,1075,0)
 ;;=OTPT PSYTX W E&M ADD-ON^10^90
 ;;^UTILITY(U,$J,358.4,1076,0)
 ;;=PSYCHOTHERAPY FOR CRISIS^15^90
 ;;^UTILITY(U,$J,358.4,1077,0)
 ;;=PROLONGED SERVICES ADD-ON^14^90
 ;;^UTILITY(U,$J,358.4,1078,0)
 ;;=INJECTIONS^6^90
 ;;^UTILITY(U,$J,358.4,1079,0)
 ;;=PREVENTIVE MEDICINE COUNSELING^11^90
 ;;^UTILITY(U,$J,358.4,1080,0)
 ;;=PREVENTIVE MEDICINE-EST PT^12^90
 ;;^UTILITY(U,$J,358.4,1081,0)
 ;;=PREVENTIVE MEDICINE-NEW PT^13^90
 ;;^UTILITY(U,$J,358.4,1082,0)
 ;;=CATEGORY III CODES^3^90
 ;;^UTILITY(U,$J,358.4,1083,0)
 ;;=TEAM CONFERENCE^16^90
 ;;^UTILITY(U,$J,358.4,1084,0)
 ;;=HOME HEALTH PROCEDURES^4^90
 ;;^UTILITY(U,$J,358.4,1085,0)
 ;;=INJECTION ADMINISTRATION^5^90
 ;;^UTILITY(U,$J,358.4,1086,0)
 ;;=ESTABLISHED PATIENT^1^91
 ;;^UTILITY(U,$J,358.4,1087,0)
 ;;=CONSULTATIONS-OUTPATIENT^3^91
 ;;^UTILITY(U,$J,358.4,1088,0)
 ;;=NEW PATIENT^2^91
 ;;^UTILITY(U,$J,358.4,1089,0)
 ;;=CONSULTATIONS-INPATIENT^4^91
 ;;^UTILITY(U,$J,358.4,1090,0)
 ;;=INITIAL HOSPITAL CARE^5^91
 ;;^UTILITY(U,$J,358.4,1091,0)
 ;;=HOSPITAL CARE DISCHARGE^7^91
 ;;^UTILITY(U,$J,358.4,1092,0)
 ;;=INITIAL OBSERVATION CARE^8^91
 ;;^UTILITY(U,$J,358.4,1093,0)
 ;;=OBSERVATION CARE DISCHARGE SERVICES^10^91
 ;;^UTILITY(U,$J,358.4,1094,0)
 ;;=INPT or ADMIT & DISCHARGE SAME DAY^11^91
 ;;^UTILITY(U,$J,358.4,1095,0)
 ;;=SUBSEQUENT HOSPITAL CARE^6^91
 ;;^UTILITY(U,$J,358.4,1096,0)
 ;;=OBSERVATION SUBSEQUENT CARE^9^91
 ;;^UTILITY(U,$J,358.4,1097,0)
 ;;=DOMICILIARY EST PATIENT^12^91
 ;;^UTILITY(U,$J,358.4,1098,0)
 ;;=DOMICILIARY NEW PATIENT^13^91
 ;;^UTILITY(U,$J,358.4,1099,0)
 ;;=HOME VISITS EST PATIENT^14^91
 ;;^UTILITY(U,$J,358.4,1100,0)
 ;;=HOME VISITS NEW PATIENT^15^91
 ;;^UTILITY(U,$J,358.4,1101,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^92
 ;;^UTILITY(U,$J,358.4,1102,0)
 ;;=ANXIETY DISORDERS^2^92
 ;;^UTILITY(U,$J,358.4,1103,0)
 ;;=BIPOLAR DISORDERS^3^92
 ;;^UTILITY(U,$J,358.4,1104,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^92
 ;;^UTILITY(U,$J,358.4,1105,0)
 ;;=DEPRESSIVE DISORDERS^7^92
 ;;^UTILITY(U,$J,358.4,1106,0)
 ;;=DISSOCIATIVE DISORDERS ^9^92
 ;;^UTILITY(U,$J,358.4,1107,0)
 ;;=FEEDING & EATING DISORDERS^12^92
 ;;^UTILITY(U,$J,358.4,1108,0)
 ;;=EDUCATIONAL/OCCUPATIONAL PROBLEMS^10^92
 ;;^UTILITY(U,$J,358.4,1109,0)
 ;;=GENDER DYSPHORIA^14^92
 ;;^UTILITY(U,$J,358.4,1110,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^92
 ;;^UTILITY(U,$J,358.4,1111,0)
 ;;=MEDICATION-INDUCED MOVEMENT DISORDERS^16^92
 ;;^UTILITY(U,$J,358.4,1112,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^92
 ;;^UTILITY(U,$J,358.4,1113,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^92
 ;;^UTILITY(U,$J,358.4,1114,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^92
 ;;^UTILITY(U,$J,358.4,1115,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^92
 ;;^UTILITY(U,$J,358.4,1116,0)
 ;;=PARAPHILIC DISORDERS^21^92
 ;;^UTILITY(U,$J,358.4,1117,0)
 ;;=PERSONALITY DISORDERS^23^92
 ;;^UTILITY(U,$J,358.4,1118,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^92
 ;;^UTILITY(U,$J,358.4,1119,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^92
 ;;^UTILITY(U,$J,358.4,1120,0)
 ;;=RELATIONAL PROBLEMS^25^92
 ;;^UTILITY(U,$J,358.4,1121,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^92
 ;;^UTILITY(U,$J,358.4,1122,0)
 ;;=SEXUAL DYSFUNCTIONS^27^92
 ;;^UTILITY(U,$J,358.4,1123,0)
 ;;=SLEEP-WAKE DISORDERS^28^92
 ;;^UTILITY(U,$J,358.4,1124,0)
 ;;=SUBSTANCE USE DISORDER-ALCOHOL^31^92
 ;;^UTILITY(U,$J,358.4,1125,0)
 ;;=SUBSTANCE USE DISORDER-CANNABIS^33^92
 ;;^UTILITY(U,$J,358.4,1126,0)
 ;;=SUBSTANCE USE DISORDER-HALLUCINOGEN^34^92
 ;;^UTILITY(U,$J,358.4,1127,0)
 ;;=SUBSTANCE USE DISORDER-OPIOID^36^92
 ;;^UTILITY(U,$J,358.4,1128,0)
 ;;=SUBSTANCE USE DISORDER-SEDATIVE/HYPNOTIC^37^92
 ;;^UTILITY(U,$J,358.4,1129,0)
 ;;=SUBSTANCE USE DISORDER-TOBACCO^39^92
 ;;^UTILITY(U,$J,358.4,1130,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^92
 ;;^UTILITY(U,$J,358.4,1131,0)
 ;;=SUBSTANCE USE DISORDER-INHALANT^35^92
 ;;^UTILITY(U,$J,358.4,1132,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^92
 ;;^UTILITY(U,$J,358.4,1133,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^92
 ;;^UTILITY(U,$J,358.4,1134,0)
 ;;=DISRUPTIVE,IMPULSE-CONTROL DISORDERS^8^92
 ;;^UTILITY(U,$J,358.4,1135,0)
 ;;=ELIMINATION DISORDERS^11^92
 ;;^UTILITY(U,$J,358.4,1136,0)
 ;;=GAMBLING DISORDER^13^92
 ;;^UTILITY(U,$J,358.4,1137,0)
 ;;=OTHER MENTAL DISORDERS^20^92
 ;;^UTILITY(U,$J,358.4,1138,0)
 ;;=NEURODEVELOPMENTAL DISORDERS^18^92
 ;;^UTILITY(U,$J,358.4,1139,0)
 ;;=SUBSTANCE USE DISORDER-CAFFEINE^32^92
 ;;^UTILITY(U,$J,358.4,1140,0)
 ;;=SUICIDAL IDEATIONS^41^92
 ;;^UTILITY(U,$J,358.4,1141,0)
 ;;=SUBSTANCE USE DISORDER-UNKNOWN SUBSTANCE^40^92
 ;;^UTILITY(U,$J,358.4,1142,0)
 ;;=SUBSTANCE USE DISORDER-STIMULANTS^38^92
 ;;^UTILITY(U,$J,358.4,1143,0)
 ;;=GROUP PSYCHOTHERAPY/INTERVENTION^2^93
 ;;^UTILITY(U,$J,358.4,1144,0)
 ;;=OTHER^8^93
 ;;^UTILITY(U,$J,358.4,1145,0)
 ;;=TEAM CONFERENCE^7^93
 ;;^UTILITY(U,$J,358.4,1146,0)
 ;;=SUBSTANCE ABUSE^6^93
 ;;^UTILITY(U,$J,358.4,1147,0)
 ;;=CASE MANAGEMENT^1^93
 ;;^UTILITY(U,$J,358.4,1148,0)
 ;;=INJECTION ADMINISTRATION^4^93
 ;;^UTILITY(U,$J,358.4,1149,0)
 ;;=INJECTIONS/MEDICATIONS^5^93
 ;;^UTILITY(U,$J,358.4,1150,0)
 ;;=IN-HOME BEHAVIOR/HEALTH ASSESSMENT^3^93
 ;;^UTILITY(U,$J,358.4,1151,0)
 ;;=ESTABLISHED PATIENT^1^94
 ;;^UTILITY(U,$J,358.4,1152,0)
 ;;=ABUSE,NEGLECT, & VIOLENCE^1^95
 ;;^UTILITY(U,$J,358.4,1153,0)
 ;;=ANXIETY DISORDERS^2^95
 ;;^UTILITY(U,$J,358.4,1154,0)
 ;;=BIPOLAR DISORDERS^3^95
 ;;^UTILITY(U,$J,358.4,1155,0)
 ;;=NEUROCOGNITIVE DISORDERS^17^95
 ;;^UTILITY(U,$J,358.4,1156,0)
 ;;=DEPRESSIVE DISORDERS^7^95
 ;;^UTILITY(U,$J,358.4,1157,0)
 ;;=DISSOCIATIVE DISORDERS ^9^95
 ;;^UTILITY(U,$J,358.4,1158,0)
 ;;=FEEDING & EATING DISORDERS^12^95
 ;;^UTILITY(U,$J,358.4,1159,0)
 ;;=EDUCATIONAL/OCCUPATIONAL PROBLEMS^10^95
 ;;^UTILITY(U,$J,358.4,1160,0)
 ;;=GENDER DYSPHORIA^14^95
 ;;^UTILITY(U,$J,358.4,1161,0)
 ;;=HOUSING/ECONOMIC PROBLEMS^15^95
 ;;^UTILITY(U,$J,358.4,1162,0)
 ;;=MEDICATION-INDUCED MOVEMENT DISORDERS^16^95
 ;;^UTILITY(U,$J,358.4,1163,0)
 ;;=OBSESSIVE-COMPULSIVE & RELATED DISORDERS^19^95
 ;;^UTILITY(U,$J,358.4,1164,0)
 ;;=PERSONAL HX & CURRENT CIRCUMSTANCES^22^95
 ;;^UTILITY(U,$J,358.4,1165,0)
 ;;=COUNSELING/MEDICAL ADVICE^5^95
 ;;^UTILITY(U,$J,358.4,1166,0)
 ;;=SOCIAL ENVIRONMENT PROBLEMS^29^95
 ;;^UTILITY(U,$J,358.4,1167,0)
 ;;=PARAPHILIC DISORDERS^21^95
 ;;^UTILITY(U,$J,358.4,1168,0)
 ;;=PERSONALITY DISORDERS^23^95
 ;;^UTILITY(U,$J,358.4,1169,0)
 ;;=CRIME/LEGAL SYSTEM PROBLEMS^6^95
 ;;^UTILITY(U,$J,358.4,1170,0)
 ;;=PSYCHOSOCIAL/PERSONAL/ENVIRONMENTAL^24^95
 ;;^UTILITY(U,$J,358.4,1171,0)
 ;;=RELATIONAL PROBLEMS^25^95
 ;;^UTILITY(U,$J,358.4,1172,0)
 ;;=SCHIZOPHRENIA/OTH PSYCHOTIC DISORDERS^26^95
 ;;^UTILITY(U,$J,358.4,1173,0)
 ;;=SEXUAL DYSFUNCTIONS^27^95
 ;;^UTILITY(U,$J,358.4,1174,0)
 ;;=SLEEP-WAKE DISORDERS^28^95
 ;;^UTILITY(U,$J,358.4,1175,0)
 ;;=SUBSTANCE USE DISORDER-ALCOHOL^31^95
 ;;^UTILITY(U,$J,358.4,1176,0)
 ;;=SUBSTANCE USE DISORDER-CANNABIS^33^95
 ;;^UTILITY(U,$J,358.4,1177,0)
 ;;=SUBSTANCE USE DISORDER-HALLUCINOGEN^34^95
 ;;^UTILITY(U,$J,358.4,1178,0)
 ;;=SUBSTANCE USE DISORDER-OPIOID^36^95
 ;;^UTILITY(U,$J,358.4,1179,0)
 ;;=SUBSTANCE USE DISORDER-SEDATIVE/HYPNOTIC^37^95
 ;;^UTILITY(U,$J,358.4,1180,0)
 ;;=SUBSTANCE USE DISORDER-TOBACCO^39^95
 ;;^UTILITY(U,$J,358.4,1181,0)
 ;;=TRAUMA/STRESSOR-RELATED DISORDERS^42^95
 ;;^UTILITY(U,$J,358.4,1182,0)
 ;;=SUBSTANCE USE DISORDER-INHALANT^35^95
 ;;^UTILITY(U,$J,358.4,1183,0)
 ;;=CLINICAL RESEARCH PROGRAM^4^95
 ;;^UTILITY(U,$J,358.4,1184,0)
 ;;=SOMATIC SYMPTOM & RELATED DISORDERS^30^95
